Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
View ORCID ProfileX Solanich, A Antolí, N Padullés, View ORCID ProfileM Fanlo-Maresma, View ORCID ProfileA Iriarte, View ORCID ProfileF Mitjavila, View ORCID ProfileO Capdevila, M Molina, View ORCID ProfileJ Sabater, View ORCID ProfileJ Bas, View ORCID ProfileA Mensa-Vilaró, View ORCID ProfileJ Niubó, View ORCID ProfileN Calvo, S Bolivar, R Rigo-Bonnin, View ORCID ProfileL Arregui, C Tebé, View ORCID ProfileP Hereu, S Videla, View ORCID ProfileX Corbella
doi: https://doi.org/10.1101/2021.01.09.21249263
X Solanich
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
A Antolí
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
N Padullés
2Departments of Pharmacy, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
M Fanlo-Maresma
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
A Iriarte
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
F Mitjavila
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
O Capdevila
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
M Molina
3Departments of Respiratory Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
J Sabater
4Departments of Intensive Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
J Bas
5Departments of Immunology, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
A Mensa-Vilaró
6Immunology Service, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
J Niubó
7Departments of Microbiology, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
N Calvo
8Departments of Diagnostic Imaging, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
S Bolivar
8Departments of Diagnostic Imaging, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
R Rigo-Bonnin
9Departments of Clinical Laboratory, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
L Arregui
10Departments of BUH-ICO-IDIBELL Biobank, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
C Tebé
11Departments of Statistics, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
P Hereu
12Departments of Clinical Pharmacology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
13Departments of Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Plataforma SCRen, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
S Videla
12Departments of Clinical Pharmacology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
13Departments of Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Plataforma SCRen, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
X Corbella
1Departments of Internal Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
14Evaluation of Health Determinants and Health Policies Group, Hestia Chair in Integrated Health and Social Care, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain
Article usage
Posted January 12, 2021.
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
X Solanich, A Antolí, N Padullés, M Fanlo-Maresma, A Iriarte, F Mitjavila, O Capdevila, M Molina, J Sabater, J Bas, A Mensa-Vilaró, J Niubó, N Calvo, S Bolivar, R Rigo-Bonnin, L Arregui, C Tebé, P Hereu, S Videla, X Corbella
medRxiv 2021.01.09.21249263; doi: https://doi.org/10.1101/2021.01.09.21249263
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
X Solanich, A Antolí, N Padullés, M Fanlo-Maresma, A Iriarte, F Mitjavila, O Capdevila, M Molina, J Sabater, J Bas, A Mensa-Vilaró, J Niubó, N Calvo, S Bolivar, R Rigo-Bonnin, L Arregui, C Tebé, P Hereu, S Videla, X Corbella
medRxiv 2021.01.09.21249263; doi: https://doi.org/10.1101/2021.01.09.21249263
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2948)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12754)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4588)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4362)
- Nursing (236)
- Nutrition (640)
- Oncology (2273)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6947)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)